086900.KQ
Medy-Tox Inc.
KOE · Healthcare · Biotechnology · KR
KRW 64,200.00
−2.43%Year over year
Reported trailing growth
- Revenue
- +7.0%
- EBITDA
- -1.3%
- EBIT
- -7.4%
- EPS
- -19.6%
- Free cash flow
- +37.4%
- Operating cash flow
- +27.3%
Forward estimates
Based on analyst estimates
- Revenue
- +9.2%
- EBITDA
- +65.0%
- EPS
- +89.4%
Three-year CAGR
- Revenue
- +8.2%
- EBITDA
- -19.6%
- EBIT
- -29.0%
- Net income
- -23.5%
- EPS
- -24.4%
- Free cash flow
- +156.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026